Torthaí cuardaigh - David A. Scheinberg
- 1 - 20 toradh as 59 á dtaispeáint
- Téigh chuig an gcéad leathanach eile
-
1
Actinium-225 in Targeted Alpha-Particle Therapeutic Applications de réir David A. Scheinberg, Michael R. McDevitt
Foilsithe / Cruthaithe 2011Revisão -
2
Realizing the potential of the Actinium-225 radionuclide generator in targeted alpha particle therapy applications de réir Matthias Miederer, David A. Scheinberg, Michael R. McDevitt
Foilsithe / Cruthaithe 2008Revisão -
3
Efficient 1-Step Radiolabeling of Monoclonal Antibodies to High Specific Activity with <sup>225</sup>Ac for α-Particle Radioimmunotherapy of Cancer de réir William F. Maguire, Michael R. McDevitt, Peter Smith‐Jones, David A. Scheinberg
Foilsithe / Cruthaithe 2014Artigo -
4
Chimeric and humanized antibodies with specificity for the CD33 antigen. de réir M S Co, N M Avdalovic, Philip Caron, Mark Avdalovic, David A. Scheinberg, Cary Queen
Foilsithe / Cruthaithe 1992Artigo -
5
-
6
Carbon nanotubes as vaccine scaffolds de réir David A. Scheinberg, Michael R. McDevitt, Tao Dao, J. Justin Mulvey, Evan N. Feinberg, Simone Alidori
Foilsithe / Cruthaithe 2013Revisão -
7
Enhanced Retention of the α-Particle-Emitting Daughters of Actinium-225 by Liposome Carriers de réir Stavroula Sofou, Barry J. Kappel, Jaspreet Singh Jaggi, Michael R. McDevitt, David A. Scheinberg, George Sgouros
Foilsithe / Cruthaithe 2007Artigo -
8
Prognostic significance of minimal residual disease detection and PML/RAR-α isoform type: long-term follow-up in acute promyelocytic leukemia de réir Joseph G. Jurcic, Stephen D. Nimer, David A. Scheinberg, Tony DeBlasio, Raymond P. Warrell, Wilson H. Miller
Foilsithe / Cruthaithe 2001Artigo -
9
-
10
A multivalent bcr-abl fusion peptide vaccination trial in patients with chronic myeloid leukemia de réir Kathleen N. S. Cathcart, Javier Pinilla‐Ibarz, Tatyana Korontsvit, Joseph E. Schwartz, Victoriya Zakhaleva, Esperanza B. Papadopoulos, David A. Scheinberg
Foilsithe / Cruthaithe 2003Artigo -
11
Structure of a TCR-Mimic Antibody with Target Predicts Pharmacogenetics de réir Niloufar Ataie, Jingyi Xiang, Neal Cheng, Elliott J. Brea, Wenjie Lu, David A. Scheinberg, Liu C, Ho Leung Ng
Foilsithe / Cruthaithe 2015Artigo -
12
Vitamin C Antagonizes the Cytotoxic Effects of Antineoplastic Drugs de réir Mark Heaney, Jeffrey R. Gardner, Nicos Karasavvas, David W. Golde, David A. Scheinberg, Emily A. Smith, Owen A. O’Connor
Foilsithe / Cruthaithe 2008Artigo -
13
Peptide Epitopes from the Wilms' Tumor 1 Oncoprotein Stimulate CD4+ and CD8+ T Cells That Recognize and Kill Human Malignant Mesothelioma Tumor Cells de réir Rena J. May, Tao Dao, Javier Pinilla‐Ibarz, Tatyana Korontsvit, Victoriya Zakhaleva, Rong H. Zhang, P. Maslak, David A. Scheinberg
Foilsithe / Cruthaithe 2007Artigo -
14
Optimized T-cell receptor-mimic chimeric antigen receptor T cells directed toward the intracellular Wilms Tumor 1 antigen de réir Sarwish Rafiq, Terence J. Purdon, Anthony F. Daniyan, Mythili Koneru, Tao Dao, C Liu, David A. Scheinberg, Renier J. Brentjens
Foilsithe / Cruthaithe 2016Artigo -
15
Rejection of immunogenic tumor clones is limited by clonal fraction de réir Ron S. Gejman, Aaron Y. Chang, Heather F. Jones, Krysta M. DiKun, A. Ari Hakimi, Andrea Schietinger, David A. Scheinberg
Foilsithe / Cruthaithe 2018Artigo -
16
A TCR-mimic antibody to WT1 bypasses tyrosine kinase inhibitor resistance in human BCR-ABL+ leukemias de réir Leonid Dubrovsky, Dmitry Pankov, Elliott J. Brea, Tao Dao, Andrew Scott, Su Yan, Richard J. O’Reilly, Liu C, David A. Scheinberg
Foilsithe / Cruthaithe 2014Artigo -
17
Opportunities and challenges for TCR mimic antibodies in cancer therapy de réir Aaron Y. Chang, Ron S. Gejman, Elliott J. Brea, Claire Y. Oh, Melissa Mathias, Dmitry Pankov, Emily Casey, Tao Dao, David A. Scheinberg
Foilsithe / Cruthaithe 2016Revisão -
18
Selective Killing of Tumor Neovasculature Paradoxically Improves Chemotherapy Delivery to Tumors de réir Freddy E. Escorcia, Erik Henke, Michael R. McDevitt, Carlos H. Villa, Peter Smith‐Jones, Ronald G. Blasberg, Robert Benezra, David A. Scheinberg
Foilsithe / Cruthaithe 2010Artigo -
19
Renal uptake of bismuth-213 and its contribution to kidney radiation dose following administration of actinium-225-labeled antibody de réir Jazmin Schwartz, Jaspreet Singh Jaggi, Joseph A. O’Donoghue, Shanming Ruan, Michael R. McDevitt, Steven M. Larson, David A. Scheinberg, John L. Humm
Foilsithe / Cruthaithe 2011Artigo -
20
A multivalent DNA aptamer specific for the B-cell receptor on human lymphoma and leukemia de réir Prabodhika Mallikaratchy, Alessandro Ruggiero, Jeffrey R. Gardner, Vitaly Kuryavyi, William F. Maguire, Mark Heaney, Michael R. McDevitt, Dinshaw J. Patel, David A. Scheinberg
Foilsithe / Cruthaithe 2010Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Biology
Medicine
Immunology
Cancer research
Internal medicine
Biochemistry
Chemistry
Genetics
Immune system
Antibody
T cell
Leukemia
Antigen
Gene
Cell biology
Cancer
Immunotherapy
In vitro
Monoclonal antibody
Pathology
Epitope
Gastroenterology
Oncology
Pharmacology
Cytotoxic T cell
Organic chemistry
Stem cell
T-cell receptor
CD8
Chemotherapy